Home › NDC Lookup › RxCUI directory › RxCUI 1862695

24 HR empagliflozin 25 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet — RxCUI 1862695

RxNorm drug concept · Semantic clinical drug
RxCUI 1862695 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1862695
Official name24 HR empagliflozin 25 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asempagliflozin 25 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet
FDA products mapped4
Package NDCs mapped10
Reported Medicaid activity (SDUD)68,136 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Empagliflozin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Jardiance does much more than just lower blood sugar. Yes, it's approved to help control blood sugar in type 2 diabetes — but it's also proven to reduce serious risks in heart fail...
  • What exactly does Jardiance do — is it just for blood sugar?
  • That's completely expected. Jardiance works by causing your kidneys to release excess glucose through your urine, and extra fluid follows along with it. This is actually part of ho...
  • Why am I urinating more often since starting this medication?
📖 Read our full Empagliflozin guide →

🕸️ Concept Web — How 24 HR empagliflozin 25 MG / metformin hydrochlor... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR empagliflozin 25 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet RxCUI 1862695

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Empagliflozin 1545653
    • Metformin 6809
    • Empagliflozin / metformin 1664314
    • Metformin hydrochloride 235743
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Synjardy 1664316
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Empagliflozin / metformin Extended Release Oral Tablet 1862684
    • Empagliflozin / metformin hydrochloride Extended Release Oral Tablet 2645846
    • Empagliflozin / metformin Oral Product 1664311
    • Empagliflozin / metformin Pill 1664312
    • Empagliflozin / metformin hydrochloride Oral Product 2662684
    • Empagliflozin / metformin hydrochloride Pill 2663631
    • Empagliflozin / metformin Extended Release Oral Tablet [Synjardy] 1862687
    • Empagliflozin / metformin hydrochloride Extended Release Oral Tablet [Synjardy] 2655509
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Empagliflozin 25 MG SCDC · 1545665
  • Metformin hydrochloride 1000 MG SCDC · 860995
  • Empagliflozin / metformin Extended Release Oral Tablet SCDF · 1862684
  • Empagliflozin / metformin hydrochloride Extended Release Oral Tablet SCDFP · 2645846
  • Empagliflozin / metformin Oral Product SCDG · 1664311
  • Empagliflozin / metformin Pill SCDG · 1664312
  • Empagliflozin / metformin hydrochloride Oral Product SCDGP · 2662684
  • Empagliflozin / metformin hydrochloride Pill SCDGP · 2663631

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 10 package NDCs
10 package NDCs map to RxCUI 1862695 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0280-73 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0280-73) Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0280-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0280-90) Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0290-59 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0290-59) Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0290-74 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0290-74) Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0295-61 1 BOTTLE in 1 CARTON (0597-0295-61) / 7 TABLET, EXTENDED RE... Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0295-78 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0295-78) Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0295-88 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0295-88) Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0300-20 1 BOTTLE in 1 CARTON (0597-0300-20) / 14 TABLET, EXTENDED R... Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0300-45 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-45) Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
00597-0300-93 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-93) Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. 2016-12-10
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.